{"id":3121,"date":"2026-06-30T12:38:00","date_gmt":"2026-06-30T12:38:00","guid":{"rendered":"https:\/\/cielcharlotte.com\/intervenn-biosciences-and-aranscia-expand-commercialization-partnership-for-glycoknow-ovarian-cancer-diagnostic-test\/"},"modified":"2026-06-30T12:38:00","modified_gmt":"2026-06-30T12:38:00","slug":"intervenn-biosciences-and-aranscia-expand-commercialization-partnership-for-glycoknow-ovarian-cancer-diagnostic-test","status":"publish","type":"post","link":"https:\/\/development.brstdev.com\/cielcharlotte\/intervenn-biosciences-and-aranscia-expand-commercialization-partnership-for-glycoknow-ovarian-cancer-diagnostic-test\/","title":{"rendered":"InterVenn Biosciences and Aranscia Expand Commercialization Partnership for GlycoKnow\u2122 Ovarian Cancer Diagnostic Test"},"content":{"rendered":"<p>Aranscia&#039;s Technology Platform to Accelerate InterVenn&#039;s Research and Commercialization Initiatives SOUTH SAN FRANCISCO, Calif. and HOUSTON, June 30, 2026 \/PRNewswire\/ &#8212;\u00a0InterVenn Biosciences, a life sciences company unlocking the value of glycoproteomics for the development of transformational healthcare solutions,\u2026<\/p>\n<p><a href=\"https:\/\/development.brstdev.com\/cielcharlotte\/wp-content\/uploads\/2026\/09\/in-hellonation-home-inspection-expert-luke-anglea-explains-what-inspectors-check-during-a-south-chicagoland-home-inspection-ai.jpglatest-news\/?prn_release=20260630PH94656\">Read the full release \u2192<\/a><\/p>\n<p><em>News provided by PR Newswire.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Aranscia&#8217;s Technology Platform to Accelerate InterVenn&#8217;s Research and Commercialization Initiatives SOUTH SAN FRANCISCO, Calif. and HOUSTON, June 30, 2026 \/PRNewswire\/ &#8212;\u00a0InterVenn Biosciences, a life sciences company unlocking the value of glycoproteomics for the development of transformational healthcare solutions,\u2026<\/p>\n","protected":false},"author":14,"featured_media":3122,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[],"class_list":["post-3121","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-community-well-being"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>InterVenn Biosciences and Aranscia Expand Commercialization Partnership for GlycoKnow\u2122 Ovarian Cancer Diagnostic Test - Ciel Charlotte<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"InterVenn Biosciences and Aranscia Expand Commercialization Partnership for GlycoKnow\u2122 Ovarian Cancer Diagnostic Test - Ciel Charlotte\" \/>\n<meta property=\"og:description\" content=\"Aranscia&#039;s Technology Platform to Accelerate InterVenn&#039;s Research and Commercialization Initiatives SOUTH SAN FRANCISCO, Calif. and HOUSTON, June 30, 2026 \/PRNewswire\/ --\u00a0InterVenn Biosciences, a life sciences company unlocking the value of glycoproteomics for the development of transformational healthcare solutions,\u2026\" \/>\n<meta property=\"og:url\" content=\"https:\/\/development.brstdev.com\/cielcharlotte\/intervenn-biosciences-and-aranscia-expand-commercialization-partnership-for-glycoknow-ovarian-cancer-diagnostic-test\/\" \/>\n<meta property=\"og:site_name\" content=\"Ciel Charlotte\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-30T12:38:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/development.brstdev.com\/cielcharlotte\/wp-content\/uploads\/2026\/09\/default-image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"384\" \/>\n\t<meta property=\"og:image:height\" content=\"253\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Ethan Parker\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ethan Parker\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/intervenn-biosciences-and-aranscia-expand-commercialization-partnership-for-glycoknow-ovarian-cancer-diagnostic-test\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/intervenn-biosciences-and-aranscia-expand-commercialization-partnership-for-glycoknow-ovarian-cancer-diagnostic-test\\\/\"},\"author\":{\"name\":\"Ethan Parker\",\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/#\\\/schema\\\/person\\\/4c5e38434c81d2ebb9c5787b29251450\"},\"headline\":\"InterVenn Biosciences and Aranscia Expand Commercialization Partnership for GlycoKnow\u2122 Ovarian Cancer Diagnostic Test\",\"datePublished\":\"2026-06-30T12:38:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/intervenn-biosciences-and-aranscia-expand-commercialization-partnership-for-glycoknow-ovarian-cancer-diagnostic-test\\\/\"},\"wordCount\":61,\"image\":{\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/intervenn-biosciences-and-aranscia-expand-commercialization-partnership-for-glycoknow-ovarian-cancer-diagnostic-test\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/intervenn-biosciences-and-aranscia-expand-commercialization-partnership-for-glycoknow-ovarian-cancer-diagnostic-test-ai.png\",\"articleSection\":[\"Community Well-Being\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/intervenn-biosciences-and-aranscia-expand-commercialization-partnership-for-glycoknow-ovarian-cancer-diagnostic-test\\\/\",\"url\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/intervenn-biosciences-and-aranscia-expand-commercialization-partnership-for-glycoknow-ovarian-cancer-diagnostic-test\\\/\",\"name\":\"InterVenn Biosciences and Aranscia Expand Commercialization Partnership for GlycoKnow\u2122 Ovarian Cancer Diagnostic Test - Ciel Charlotte\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/intervenn-biosciences-and-aranscia-expand-commercialization-partnership-for-glycoknow-ovarian-cancer-diagnostic-test\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/intervenn-biosciences-and-aranscia-expand-commercialization-partnership-for-glycoknow-ovarian-cancer-diagnostic-test\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/intervenn-biosciences-and-aranscia-expand-commercialization-partnership-for-glycoknow-ovarian-cancer-diagnostic-test-ai.png\",\"datePublished\":\"2026-06-30T12:38:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/#\\\/schema\\\/person\\\/4c5e38434c81d2ebb9c5787b29251450\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/intervenn-biosciences-and-aranscia-expand-commercialization-partnership-for-glycoknow-ovarian-cancer-diagnostic-test\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/intervenn-biosciences-and-aranscia-expand-commercialization-partnership-for-glycoknow-ovarian-cancer-diagnostic-test\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/intervenn-biosciences-and-aranscia-expand-commercialization-partnership-for-glycoknow-ovarian-cancer-diagnostic-test\\\/#primaryimage\",\"url\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/intervenn-biosciences-and-aranscia-expand-commercialization-partnership-for-glycoknow-ovarian-cancer-diagnostic-test-ai.png\",\"contentUrl\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/intervenn-biosciences-and-aranscia-expand-commercialization-partnership-for-glycoknow-ovarian-cancer-diagnostic-test-ai.png\",\"width\":1536,\"height\":1024,\"caption\":\"InterVenn Biosciences and Aranscia Expand Commercialization Partnership for GlycoKnow\u2122 Ovarian Cancer Diagnostic Test\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/intervenn-biosciences-and-aranscia-expand-commercialization-partnership-for-glycoknow-ovarian-cancer-diagnostic-test\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"InterVenn Biosciences and Aranscia Expand Commercialization Partnership for GlycoKnow\u2122 Ovarian Cancer Diagnostic Test\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/#website\",\"url\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/\",\"name\":\"Ciel Charlotte\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/#\\\/schema\\\/person\\\/4c5e38434c81d2ebb9c5787b29251450\",\"name\":\"Ethan Parker\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/ethan-parkar-96x96.jpeg\",\"url\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/ethan-parkar-96x96.jpeg\",\"contentUrl\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/ethan-parkar-96x96.jpeg\",\"caption\":\"Ethan Parker\"},\"description\":\"Ethan Parker covers stories about community life, personal well-being, local initiatives, lifestyle trends, and the people working to create stronger communities. His writing looks for the human element behind larger developments, focusing on practical ideas and meaningful stories. Ethan brings an approachable perspective to subjects involving everyday life, community participation, creativity, and social connection.\",\"url\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/author\\\/ethan-parker\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"InterVenn Biosciences and Aranscia Expand Commercialization Partnership for GlycoKnow\u2122 Ovarian Cancer Diagnostic Test - Ciel Charlotte","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"InterVenn Biosciences and Aranscia Expand Commercialization Partnership for GlycoKnow\u2122 Ovarian Cancer Diagnostic Test - Ciel Charlotte","og_description":"Aranscia's Technology Platform to Accelerate InterVenn's Research and Commercialization Initiatives SOUTH SAN FRANCISCO, Calif. and HOUSTON, June 30, 2026 \/PRNewswire\/ --\u00a0InterVenn Biosciences, a life sciences company unlocking the value of glycoproteomics for the development of transformational healthcare solutions,\u2026","og_url":"https:\/\/development.brstdev.com\/cielcharlotte\/intervenn-biosciences-and-aranscia-expand-commercialization-partnership-for-glycoknow-ovarian-cancer-diagnostic-test\/","og_site_name":"Ciel Charlotte","article_published_time":"2026-06-30T12:38:00+00:00","og_image":[{"width":384,"height":253,"url":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-content\/uploads\/2026\/09\/default-image.jpg","type":"image\/jpeg"}],"author":"Ethan Parker","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Ethan Parker"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/development.brstdev.com\/cielcharlotte\/intervenn-biosciences-and-aranscia-expand-commercialization-partnership-for-glycoknow-ovarian-cancer-diagnostic-test\/#article","isPartOf":{"@id":"https:\/\/development.brstdev.com\/cielcharlotte\/intervenn-biosciences-and-aranscia-expand-commercialization-partnership-for-glycoknow-ovarian-cancer-diagnostic-test\/"},"author":{"name":"Ethan Parker","@id":"https:\/\/development.brstdev.com\/cielcharlotte\/#\/schema\/person\/4c5e38434c81d2ebb9c5787b29251450"},"headline":"InterVenn Biosciences and Aranscia Expand Commercialization Partnership for GlycoKnow\u2122 Ovarian Cancer Diagnostic Test","datePublished":"2026-06-30T12:38:00+00:00","mainEntityOfPage":{"@id":"https:\/\/development.brstdev.com\/cielcharlotte\/intervenn-biosciences-and-aranscia-expand-commercialization-partnership-for-glycoknow-ovarian-cancer-diagnostic-test\/"},"wordCount":61,"image":{"@id":"https:\/\/development.brstdev.com\/cielcharlotte\/intervenn-biosciences-and-aranscia-expand-commercialization-partnership-for-glycoknow-ovarian-cancer-diagnostic-test\/#primaryimage"},"thumbnailUrl":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-content\/uploads\/2026\/06\/intervenn-biosciences-and-aranscia-expand-commercialization-partnership-for-glycoknow-ovarian-cancer-diagnostic-test-ai.png","articleSection":["Community Well-Being"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/development.brstdev.com\/cielcharlotte\/intervenn-biosciences-and-aranscia-expand-commercialization-partnership-for-glycoknow-ovarian-cancer-diagnostic-test\/","url":"https:\/\/development.brstdev.com\/cielcharlotte\/intervenn-biosciences-and-aranscia-expand-commercialization-partnership-for-glycoknow-ovarian-cancer-diagnostic-test\/","name":"InterVenn Biosciences and Aranscia Expand Commercialization Partnership for GlycoKnow\u2122 Ovarian Cancer Diagnostic Test - Ciel Charlotte","isPartOf":{"@id":"https:\/\/development.brstdev.com\/cielcharlotte\/#website"},"primaryImageOfPage":{"@id":"https:\/\/development.brstdev.com\/cielcharlotte\/intervenn-biosciences-and-aranscia-expand-commercialization-partnership-for-glycoknow-ovarian-cancer-diagnostic-test\/#primaryimage"},"image":{"@id":"https:\/\/development.brstdev.com\/cielcharlotte\/intervenn-biosciences-and-aranscia-expand-commercialization-partnership-for-glycoknow-ovarian-cancer-diagnostic-test\/#primaryimage"},"thumbnailUrl":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-content\/uploads\/2026\/06\/intervenn-biosciences-and-aranscia-expand-commercialization-partnership-for-glycoknow-ovarian-cancer-diagnostic-test-ai.png","datePublished":"2026-06-30T12:38:00+00:00","author":{"@id":"https:\/\/development.brstdev.com\/cielcharlotte\/#\/schema\/person\/4c5e38434c81d2ebb9c5787b29251450"},"breadcrumb":{"@id":"https:\/\/development.brstdev.com\/cielcharlotte\/intervenn-biosciences-and-aranscia-expand-commercialization-partnership-for-glycoknow-ovarian-cancer-diagnostic-test\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/development.brstdev.com\/cielcharlotte\/intervenn-biosciences-and-aranscia-expand-commercialization-partnership-for-glycoknow-ovarian-cancer-diagnostic-test\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/development.brstdev.com\/cielcharlotte\/intervenn-biosciences-and-aranscia-expand-commercialization-partnership-for-glycoknow-ovarian-cancer-diagnostic-test\/#primaryimage","url":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-content\/uploads\/2026\/06\/intervenn-biosciences-and-aranscia-expand-commercialization-partnership-for-glycoknow-ovarian-cancer-diagnostic-test-ai.png","contentUrl":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-content\/uploads\/2026\/06\/intervenn-biosciences-and-aranscia-expand-commercialization-partnership-for-glycoknow-ovarian-cancer-diagnostic-test-ai.png","width":1536,"height":1024,"caption":"InterVenn Biosciences and Aranscia Expand Commercialization Partnership for GlycoKnow\u2122 Ovarian Cancer Diagnostic Test"},{"@type":"BreadcrumbList","@id":"https:\/\/development.brstdev.com\/cielcharlotte\/intervenn-biosciences-and-aranscia-expand-commercialization-partnership-for-glycoknow-ovarian-cancer-diagnostic-test\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/development.brstdev.com\/cielcharlotte\/"},{"@type":"ListItem","position":2,"name":"InterVenn Biosciences and Aranscia Expand Commercialization Partnership for GlycoKnow\u2122 Ovarian Cancer Diagnostic Test"}]},{"@type":"WebSite","@id":"https:\/\/development.brstdev.com\/cielcharlotte\/#website","url":"https:\/\/development.brstdev.com\/cielcharlotte\/","name":"Ciel Charlotte","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/development.brstdev.com\/cielcharlotte\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/development.brstdev.com\/cielcharlotte\/#\/schema\/person\/4c5e38434c81d2ebb9c5787b29251450","name":"Ethan Parker","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-content\/uploads\/2026\/09\/ethan-parkar-96x96.jpeg","url":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-content\/uploads\/2026\/09\/ethan-parkar-96x96.jpeg","contentUrl":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-content\/uploads\/2026\/09\/ethan-parkar-96x96.jpeg","caption":"Ethan Parker"},"description":"Ethan Parker covers stories about community life, personal well-being, local initiatives, lifestyle trends, and the people working to create stronger communities. His writing looks for the human element behind larger developments, focusing on practical ideas and meaningful stories. Ethan brings an approachable perspective to subjects involving everyday life, community participation, creativity, and social connection.","url":"https:\/\/development.brstdev.com\/cielcharlotte\/author\/ethan-parker\/"}]}},"_links":{"self":[{"href":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-json\/wp\/v2\/posts\/3121","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-json\/wp\/v2\/comments?post=3121"}],"version-history":[{"count":0,"href":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-json\/wp\/v2\/posts\/3121\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-json\/wp\/v2\/media\/3122"}],"wp:attachment":[{"href":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-json\/wp\/v2\/media?parent=3121"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-json\/wp\/v2\/categories?post=3121"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-json\/wp\/v2\/tags?post=3121"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}